Andrew Zehner currently serves as the Senior Director of Legal Affairs at the University of Pennsylvania Gene Therapy Program. Andrew has twenty-five years of experience providing strategic and business counsel to a wide variety of industries, including life sciences, health care, telecommunications, and information technology. Prior to Penn, he worked as Associate Vice President for Technology Commercialization at the University of Connecticut and counsel in the Office of the General Counsel. Earlier in his career, Andrew worked as Senior Corporate Counsel for Pfizer Inc., supporting all aspects of pharmaceutical R&D in the U.S. and United Kingdom.